Squar Milner Financial Services’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Squar Milner Financial Services’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50	Closed	–	–	904
2018 Q2	$0	Buy	+50	New	+$15	﹤0.01%	855

Other funds holding ANTH

VCM

Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return

Squar Milner Financial Services's ANTH Position: Q3 2018 in Review

Squar Milner Financial Services sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2018, closing a stake of 50 shares.

Squar Milner Financial Services first reported a position in ANTH in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 1 fund tracked by Wall St. Rank holds ANTH as of Q3 2018.

Squar Milner Financial Services reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Squar Milner Financial Services sold 50 Anthera Pharmaceuticals, Inc. shares in Q3 2018.
Squar Milner Financial Services first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2018 and held it in 1 quarter.
Squar Milner Financial Services's Anthera Pharmaceuticals, Inc. position peaked at $0 in Q2 2018.
1 fund tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2018.

Based on Squar Milner Financial Services's 13F filing for Q3 2018, filed 29 Oct 2018.